These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38776442)

  • 1. Incidence of Bacteremia and Serious Bacterial Infections in Hyperpyrexic Infants Offered Universal Pneumococcal Conjugate Vaccine 13 and Haemophilus influenzae B Immunization.
    Be'er M; Rimon A; Segev O; Huber A; Scolnik D; Glatstein M
    Pediatr Emerg Care; 2024 Aug; 40(8):e143-e146. PubMed ID: 38776442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of invasive pneumococcal and Haemophilus influenzae diseases in Northwestern Ontario, Canada, 2010-2015.
    Eton V; Schroeter A; Kelly L; Kirlew M; Tsang RSW; Ulanova M
    Int J Infect Dis; 2017 Dec; 65():27-33. PubMed ID: 28951105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity and safety of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine (PHiD-CV) co-administered with routine childhood vaccines in Taiwan.
    Lin TY; Lu CY; Chang LY; Chiu CH; Huang YC; Bock HL; Tang H; François N; Moreira M; Schuerman L; Huang LM
    J Formos Med Assoc; 2012 Sep; 111(9):495-503. PubMed ID: 23021506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An open-label randomized clinical trial of prophylactic paracetamol coadministered with 7-valent pneumococcal conjugate vaccine and hexavalent diphtheria toxoid, tetanus toxoid, 3-component acellular pertussis, hepatitis B, inactivated poliovirus, and Haemophilus influenzae type b vaccine.
    Rose MA; Juergens C; Schmoele-Thoma B; Gruber WC; Baker S; Zielen S
    BMC Pediatr; 2013 Jun; 13():98. PubMed ID: 23786774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Bacteremia with Vaccination Status in Children Aged 2 to 36 Months.
    Dunnick J; Taft M; Tisherman RT; Nowalk AJ; Hickey RW; Wilson PM
    J Pediatr; 2021 May; 232():207-213.e2. PubMed ID: 33453206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population-based incidence of invasive haemophilus influenzae and pneumococcal diseases before the introduction of vaccines in Japan.
    Nakamura R; Togashi T
    Pediatr Infect Dis J; 2013 Dec; 32(12):1394-6. PubMed ID: 23804122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the introduction of the Haemophilus influenzae type b conjugate vaccine in an urban setting in southern India.
    Fitzwater SP; Ramachandran P; Kahn GD; Nedunchelian K; Suresh S; Santosham M; Chandran A
    Vaccine; 2019 Mar; 37(12):1608-1613. PubMed ID: 30772069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serious bacterial infections in febrile infants in the post-pneumococcal conjugate vaccine era.
    Rudinsky SL; Carstairs KL; Reardon JM; Simon LV; Riffenburgh RH; Tanen DA
    Acad Emerg Med; 2009 Jul; 16(7):585-90. PubMed ID: 19538500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Burden of invasive disease caused by Haemophilus influenzae type b in Bamako, Mali: impetus for routine infant immunization with conjugate vaccine.
    Sow SO; Diallo S; Campbell JD; Tapia MD; Keita T; Keita MM; Murray P; Kotloff KL; Levine MM
    Pediatr Infect Dis J; 2005 Jun; 24(6):533-7. PubMed ID: 15933564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological effect of administration of sequential doses of Haemophilus influenzae type b and pneumococcal conjugate vaccines in the same versus alternating limbs in the routine infant immunisation schedule: an open-label randomised controlled trial.
    Iro MA; Khatami A; Marshall AS; Pace D; Voysey M; McKenna J; Campbell D; Attard-Montalto S; Finn A; White C; Faust SN; Kent A; Heath PT; MacLeod E; Stanford E; Findlow H; Almond R; Bai X; Borrow R; Snape MD; Pollard AJ
    Lancet Infect Dis; 2015 Feb; 15(2):172-80. PubMed ID: 25577661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and reactogenicity of a pneumococcal conjugate vaccine administered combined with a haemophilus influenzae type B conjugate vaccine in United Kingdom infants.
    Choo S; Seymour L; Morris R; Quataert S; Lockhart S; Cartwright K; Finn A
    Pediatr Infect Dis J; 2000 Sep; 19(9):854-62. PubMed ID: 11001109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-type b Haemophilus influenzae disease: clinical and epidemiologic characteristics in the Haemophilus influenzae type b vaccine era.
    Heath PT; Booy R; Azzopardi HJ; Slack MP; Fogarty J; Moloney AC; Ramsay ME; Moxon ER
    Pediatr Infect Dis J; 2001 Mar; 20(3):300-5. PubMed ID: 11303834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling the impact of a new vaccine on pneumococcal and nontypable Haemophilus influenzae diseases: a new simulation model.
    De Wals P; Black S; Borrow R; Pearce D
    Clin Ther; 2009 Oct; 31(10):2152-69. PubMed ID: 19922887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and antibody persistence following Haemophilus influenzae type b conjugate or pneumococcal polysaccharide vaccines given before pregnancy in women of childbearing age and their infants.
    Santosham M; Englund JA; McInnes P; Croll J; Thompson CM; Croll L; Glezen WP; Siber GR
    Pediatr Infect Dis J; 2001 Oct; 20(10):931-40. PubMed ID: 11642626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of Haemophilus influenzae type b and pneumococcal conjugate vaccines on childhood pneumonia incidence, severe morbidity and mortality.
    Theodoratou E; Johnson S; Jhass A; Madhi SA; Clark A; Boschi-Pinto C; Bhopal S; Rudan I; Campbell H
    Int J Epidemiol; 2010 Apr; 39 Suppl 1(Suppl 1):i172-85. PubMed ID: 20348119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct Comparison of Immunogenicity Induced by 10- or 13-Valent Pneumococcal Conjugate Vaccine around the 11-Month Booster in Dutch Infants.
    Wijmenga-Monsuur AJ; van Westen E; Knol MJ; Jongerius RM; Zancolli M; Goldblatt D; van Gageldonk PG; Tcherniaeva I; Berbers GA; Rots NY
    PLoS One; 2015; 10(12):e0144739. PubMed ID: 26658902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Haemophilus influenzae type b vaccination without a booster dose on invasive H influenzae type b disease, nasopharyngeal carriage, and population immunity in Kilifi, Kenya: a 15-year regional surveillance study.
    Hammitt LL; Crane RJ; Karani A; Mutuku A; Morpeth SC; Burbidge P; Goldblatt D; Kamau T; Sharif S; Mturi N; Scott JA
    Lancet Glob Health; 2016 Mar; 4(3):e185-94. PubMed ID: 26853149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does extreme leukocytosis predict serious bacterial infections in infants in the post-pneumococcal vaccine era? The experience of a large, tertiary care pediatric hospital.
    Danino D; Rimon A; Scolnik D; Grisaru-Soen G; Glatstein M
    Pediatr Emerg Care; 2015 Jun; 31(6):391-4. PubMed ID: 25996230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced use of occult bacteremia blood screens by emergency medicine physicians using immunization registry for children presenting with fever without a source.
    Zeretzke CM; McIntosh MS; Kalynych CJ; Wylie T; Lott M; Wood D
    Pediatr Emerg Care; 2012 Jul; 28(7):640-5. PubMed ID: 22743750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global status of Haemophilus influenzae type b and pneumococcal conjugate vaccines: evidence, policies, and introductions.
    Levine OS; Knoll MD; Jones A; Walker DG; Risko N; Gilani Z
    Curr Opin Infect Dis; 2010 Jun; 23(3):236-41. PubMed ID: 20407316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.